Government of Mali Report issue

Government

Organization Overview

First Clinical Trial
2016
NCT03035305
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Malian Ministry of Health and Public Hygiene | Ministry of health, Mali

Active Ingredients

Drugs in Other Trials (3)

amodiaquine (camoquin) (1 trial)

pyrimethamine (daraprim) (1 trial)

sulfadoxine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3